Structure, function, and evolution of adenovirus-associated RNA: A phylogenetic approach

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 5083-5099

  Ma, Yuliang ^a,b,c   Mathews, Michael B ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADENOVIRUS; ARTICLE; DNA SEQUENCE; EVOLUTION; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA STRUCTURE; SEROTYPING; STRUCTURE ACTIVITY RELATION; VIRAL GENETICS; VIRUS TRANSCRIPTION;

EID: 0029978646     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.5083-5099.1996     Document Type: Article

References (78)

1. Adrian, T., and R. Wigand. 1989. Genome type analysis of adennvirus 31, a potential causative agent of infants' enteritis. Arch. Virol. 105:81-87.
2. II of adenovirus type 2. Proc. Natl. Acad. Sci. USA 77:2424-2428.
3. Bailey, A., and V. Mautner. 1994. Phylogenetic relationships among adenovirus serotypes. Virology 205:438-452.
4. Bartel, D. P., M. L. Zapp, M. R. Green, and J. W. Szostak. 1991. HIV-1 Rev regulation involves recognition of non-Watson-Crick hase pairs in viral RNA. Cell 67:529-536.
5. Bhat, R. A., P. H. Domer, and B. Thimmappaya. 1985. Structural requirements of adenovirus VAI RNA for its translation enhancement function. Mol. Cell. Biol. 5:187-196.
6. Bhat, R. A., B. Metz, and B. Thimmappaya. 1983. Organization of the noncontiguous promoter components of adenovirus VAI RNA gene is strikingly similar to that of eucaryotic genes. Mol. Cell. Biol. 3:1996-2005.
7. Bhat, R. A., and B. Thimmappaya. 1984. Adenovirus mutants with DNA sequence perturbations in the intragenic promoter of VAI RNA gene allow the enhanced transcription of VAII RNA gene in HeLa cells. Nucleic Acids Res. 12:7377-7388.
8. Bogenhagen, D. F., and D. D. Brown. 1981. Nucleotidc sequences in Xenopus SS DNA required for transcription termination. Cell 24:261-270.
9. Circle, D. A., O. D. Neel, P. Clarke, L. Manche, M. B. Mathews, and H. D. Robertson. Unpublished data.
10. Clarke, P. A., and M. B. Mathews. 1995. Interactions between the double-stranded RNA binding motif and RNA: definition of the binding site for the interferon-induced protein kinase DAI (PKR) on adenovirus VA RNA. RNA 1:7-20.
11. Clarke, P. A., T. Pe'ery, Y. Ma, and M. B. Mathews. 1994. Structural features of adenovirus 2 virus-associated RNA required for binding to the protein kinase DAJ. Nucleic Acids Res. 22:4364-4374.
12. Daniels, G. R., and P. L. Deininger. 1983. A second major class of Alu family derived from mammalian (RNA genes. Nucleic Acids Res. 11:7595-7610.
13. Daniels, G. R., and P. L. Deininger. 1991. Characterization of a third major SINE family of repetitive sequences in the galago genome. Nucleic Acids Res. 19:1649-1656.
14. England, T. E., and O. C. Uhlenbeck. 1978. 3′-terminal labelling of RNA with T4 RNA ligase. Nature (London) 275:560-561.
15. Engler, J. A., M. S. Hoppe, and M. P. van Bree. 1983. The nucleotide sequence of the genes encoded in early region 2b of human adenovirus type 7. Gene 21:145-159.
16. Felsenstein, J. 1993. PHYLIP (phylogeny interface package) version 3.5c. Distributed by the author and available through anonymous ftp to evolution.genetics.washington.edu.
17. Fowlkes, D. M., and T. Shenk. 1980. Transcriptional control regions of the adenovirus VAI RNA gene. Cell 22:405-413.
18. Furtado, M. R., S. Subramanian, R. A. Bhat, D. M. Fowlkes, B. Safer, and B. Thimmappaya. 1989. Functional dissection of adenovirus VAI RNA. J. Virol. 63:3423-3434.
19. Galli, G., H. Hofstetter, and M. L. Birnstiel. 1981. Two conserved sequence blocks within eukaryotic tRNA genes are major promoter elements. Nature (London) 294:626-631.
20. Garon, C. F., K. W. Berry, J. C. Hierholzer, and J. A. Rose. 1973. Mapping of base sequence heterologies between genomes from different adenovirus serotypes. Virology 54:414-426.
21. Garrett, R. A., and S. O. Olesen. 1982. Structure of eukaryotic 5S ribonucleic acid: a study of Saccharomyces cerevisiae 5S ribonucleic acid with ribonucleases. Biochemistry 21:4823-4830.
22. Gary, G. W. J., J. C. Hierholzer, and R. E. Black. 1979. Characteristics of noncultivable adenoviruses associated with diarrhea in infants: a new sub-group of human adenoviruscs. J. Clin. Microbiol. 10:96-103.
23. Geiduschek, E. P., and G. P. Tocchini-Valentini. 1988. Transcription by RNA polymerase III. Annu. Rev. Biochcm. 57:873-914.
24. Ghadge, G. D., P. Malhotra, M. R. Furtado, R. Dhar, and B. Thimmapaya. 1994. In vitro analysis of virus-associated RNA1 (VAI RNA): inhibition of the double-stranded RNA-activated protein kinase PKR by the VAI RNA mutants correlates with the in vivo phenotype and the structural integrity of the central domain. J. Virol. 68:4137-4151.
25. Ghadge, G. D., S. Swaminathan, M. G. Katze, and B. Thimmapaya. 1991. Binding of the adenovirus VAI RNA to the interferon-induced 68 KDA protein kinase correlates with function. Proc. Natl. Acad. Sci. USA 88:7140-7144.
26. Gilbert, D. G. 1990. MulFold, a Macintosh version of MFOLD (version 2.0) by Michael Zuker and John Jaeger for prediction of RNA secondary structure by free energy minimization. Available via anonymous ftp to iubio-.bio.indiana.edu.
27. Green, S. R., L. Manche, and M. B. Mathews. 1995. Two functionally distinct RNA binding motifs in the regulatory domain of the protein kinase DAI. Mol. Cell. Biol. 15:358-364.
28. Guilfoyle, R., and R. Weinmann. 1981. Control region for adenovirus VA RNA transcription. Proc. Natl. Acad. Sci. USA 78:3378-3382.
29. Hein, J. 1990. TreeAlign, a multiple sequence alignment program that builds tree as it align DNA or protein sequences. Version 90, May. Available through anonymous ftp to ftp.embl-heidelberg.de.
30. Hein, J. 1994. TreeAlign. Methods Mol. Biol 25:349-364.
31. Huang, J. T., and R. J. Schneider. 1990. Adenovirus inhibition of cellular protein synthesis is prevented by the drug 2-aminopurine. Proc. Natl. Acad. Sci. USA 87:7115-7119.
32. Kaufman, R. J., and P. Murtha. 1987. Translational control mediated by eukaryotic initiation factor 2 is restricted to specific mRNAs in transfected cells. Mol. Cell. Biol. 7:1568-1571.
33. Kidd, A. H., D. Garwicz, and M. Oberg. 1995. Human and simian udenoviruses: phylogenetic inferences from analysis of VA RNA genes. Virology 207:32-45.
34. Kitajewski, J., R. J. Schneider, B. Safer, S. M. Munemitsu, C. E. Samuel, B. Thimmappaya, and T. Shenk. 1986. Adenovirus VAI RNA antagonizes the antiviral action of Interferon by preventing activation of the interferon-induced elF-2a kinase. Cell 45:195-200.
35. Kostura, M., and M. B. Mathews. 1989. Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol. Cell. Biol. 9:1576-1586.
36. Krayev, A. S., T. V. Markuseva, D. A. Kramerov, A. P. Ryshov, K. G. Skyrabin, A. A. Bayev, and G. P. Georgiev. 1982. Ubiquitous transposon-like repeats B1 and B2 of mouse genome: B2 sequencing. Nucleic Acids Res. 10: 7461-7475.
37. Larsson, S., C. Svensson, and G. Akusjärvi. 1986. Characterization of a low-molecular-weight virus-associated (VA) RNA encoded by simian adenovirus type 7 which functionally can substitute for adenovirus type 5 VA RNAI. J. Virol. 60:635-644.
38. Liao, H., and M. B. Mathews. Unpublished data.
39. Ma, Y., and M. B. Mathews. 1993. Comparative analysis of the structure and function of adenovirus virus-associated RNAs. J. Virol. 67:6605-6617.
40. I. Submitted for publication.
41. Maran, A., and M. B. Mathews. 1988. Characterization of the double-stranded RNA implicated in the inhibition of protein synthesis in cells infected with a mutant adenovirus defective for VA RNA,. Virology 164: 106-113.
42. Mathews, M. B. 1975. Genes for VA-RNA in adenovirus 2. Cell 6:223-229.
43. Mathews, M. B. 1993. Viral evasion of cellular defense mechanisms: regulation of the protein kinase DAI by RNA effectors. Semin. Virol. 4:247-257.
44. Mathews, M. B. 1996. Interactions between viruses and the cellular machinery for protein synthesis, p. 505-548. In J. W. B. Hershey. M. B. Mathews, and N. Sonenberg (ed.), Translational control. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
45. Mathews, M. B., and A. M. Francoeur. 1984. La antigen recognizes and binds to the 3′-oligouridylate tail of a small RNA. Mol. Cell. Biol. 4:1134-1140.
46. Mathews, M. B., and T. Grodzicker. 1981. Virus-associated RNAs of naturally occurring strains and variants of group C adenoviruses. J. Virol. 38: 849-862.
47. Mathews, M. B., and T. Shenk. 1991. Adenovirus virus-associated RNA and translational control. J. Virol. 65:5657-5662.
48. 1 with the protein kinase DA1: non-equivalence of binding and function. Cell 61:843-852.
49. I. EMBO J. 7:2849-2859.
50. Mellits, K. H., T. Pe'ery, and M. B. Mathews. 1992. Role of the apical stem in maintaining the structure and function of adenovirus virus-associated RNA stem. J. Virol. 66:2369-2377.
51. Milner, R. J., F. E. Bloom, C. Lai, R. A. Lerner, and J. G. Sutcliffe. 1984. Brain specific genes have identifier sequences in their introns. Proc. Natl. Acad. Sci. USA 81:713-717.
52. O'Donnell, B., E. A. McCruden, and U. Desselberger. 1993. Molecular epidemiology of adenovirus conjunctivitis in Glasgow 1981-1991. Eye 7:8-14.
53. O'Malley, R. P., R. F. Duncan, J. W. B. Hershey, and M. B. Mathews. 1989. Modification of protein synthesis initiation factors and shut-off of host protein synthesis in adenovirus-infected cells. Virology 168:112-118.
54. 1. Cell 44:391-400.
55. Pe'ery, T., K. H. Mellits, and M. B. Mathews. 1993. Mutational analysis of the central domain of adenovirus VA RNA mandates a revision of the proposed secondary structure, J. Virol. 67:3534-3543.
56. Rahman, A., P. Malhotra, R. Dhar, T. Kewalramani, and B. Thimmapaya. 1995. Effect of single-base substitutions in the central domain of VAI RNA on its function. J. Virol. 69:4299-4307.
57. Reich, P. R., J. Rose, B. Forget, and S. M. Weissman. 1966. RNA of low molecular weight in KB cells infected with Ad2. J. Mol. Biol. 17:428-439.
58. Reichel, P. A., W. C. Merrick, J. Siekierka, and M. B. Mathews. 1985. Regulation of a protein synthesis initiation factor by adenovirus virus-associated RNAI. Nature (London) 313:196-200.
59. I gene. J. Biol. Chem. 262:8500-8507.
60. Schmedt, C., D. R. Taylor, L. Manche, S. R. Green, Y. Ma, and M. B. Mathews. 1995. Functional characterization of the RNA binding domain and motif of the double-stranded RNA-dependent protein kinase DAI, J. Mol. Biol. 249:29-44.
61. Schmitz, H., R. Wigand, and W. Heinrich. 1983. Worldwide epidemiology of human adenovirus infections. Am. J. Epidemiol. 117:455-466.
62. Schneider, R. J. 1996. Adenovirus and vaccinia virus translational control, p. 575-605. In J. W. B. Hershey, M. B. Mathews, and N. Sonenberg (ed.), Translational control. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
63. Schneider, R. J., C. Weinberger, and T. Shenk. 1984. Adenovirus VAI RNA facilitates the initiation of translation in virus-infected cells. Cell 37:291-298.
64. Sharp, I. R., and G. Wadell. 1994. Adenoviruses, p. 287-308. In A. J. Zuckerman, J. E. Banatvala, and J. R. Pattison (ed.), Principles and practice of clinical virology. John Wiley & Sons, Chichester, England.
65. Shu, L. M., J. S. Hong, Y. F. Wei, and J. A. Engler. 1986. Nucleotide sequence of the genes encoded in early region 2b of human adenovirus type 12. Gene 46:187-195.
66. I during adenovirus infection results in phosphorylation of initiation factor eIF-2 and inhibition of protein synthesis. Proc. Natl. Acad. Sci. USA 82:1959-1963.
67. Snouwaert, J., D. Bunick, C. Hutchison, and D. M. Fowlkes. 1987. Large numbers of random point and cluster mutations within the adenovirus VA I gene allow characterization of sequences required for efficient transcription. Nucleic Acids Res. 15:8293-8330.
68. Söderlund, H., U. Pettersson, B. Vennström, L. Philipson, and M. B. Mathews. 1976. A new species of virus-coded low molecular weight RNA from cells infected with Ad2. Cell 7:585-593.
69. I mediates a translational stimulation which is not restricted to the viral mRNAs. EMBO J. 4:957-964.
70. I on cytoplasmic mRNA abundance. Virology 174:613-617.
71. Takafuji, E. T., J. C. Gaydos, R. G. Allen, and F. H. J. Top. 1979. Simultaneous administration of live, enteric-coated adenovirus types 4, 7 and 21 vaccines: safety and immunogenicity. J. Infect. Dis. 140:48-53.
72. Thimmappaya, B., N. Jones, and T. Shenk. 1979. A mutation which alters initiation of transcription by RNA polymerase III on the Ad5 chromosome. Cell 18:947-954.
73. Thimmappaya, B., C. Weinberger, R. J. Schneider, and T. Shenk. 1982. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 31:543-551.
74. Wadell, G., M. L. Haimnarskjöld. G. Winberg, T. M. Varsanyi, and G. Sundell. 1980. Genetic variability of adenoviruses. Ann. N.Y. Acad. Sci. 354: 16-42.
75. Wimberly, B., G. Varani, and I. Tinoco, Jr. 1993. The conformation of loop E of eukaryotic 5S ribosomal RNA. Biochemistry 32:1078-1087.
76. Wu, G. J., J. F. Railey, and R. E. Cannon. 1987. Denning the functional domains in the control region of the adenovirus type 2 specific VA RNAI gene. J. Mol. Biol. 194:423-442.
77. Zuker, M. 1989. On finding all suboptimal foldings of an RNA molecule. Science 244:48-52.
78. Zuker, M., and P. Stiegler. 1981. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res. 9:133-148.